International Journal of Plant Research

p-ISSN: 2163-2596    e-ISSN: 2163-260X

2012;  2(2): 31-35

doi: 10.5923/j.plant.20120202.06

A Histopathological Analyses of in vivo Anti-tumor Effect of an Aqueous Extract of Aristolochia longa Used in Cancer Treatment in Traditional Medicine in Morocco

Ghita Benzakour 1, Mariam Amrani 2, Mounia Oudghiri 1

1Laboratory of Physiology and Molecular Genetics, Department of Biology, Faculty of Sciences Aïn Chock, University Hassan II, B.P 5366 Maarif, Casablanca, Morocco

2Laboratory of pathology, National Institute of Oncology, Moulay Abdallah Hospital, Rabat, Morocco

Correspondence to: Mounia Oudghiri , Laboratory of Physiology and Molecular Genetics, Department of Biology, Faculty of Sciences Aïn Chock, University Hassan II, B.P 5366 Maarif, Casablanca, Morocco.

Email:

Copyright © 2012 Scientific & Academic Publishing. All Rights Reserved.

Abstract

In Morocco, Aristolochia longa L. (AL) is commonly used in cancer treatment. The in vivo anti-tumour effect of this plant has never been investigated before. We therefore developed an experimental gingival hyperplasia model in immune-competent rats to study the in vivo action of an aqueous extract of AL on the evolution of the hyperplasia during the initiation and post-initiation phases of 4NQO-induced gingival tumorigenesis. We also aimed to understand its toxicological potential and to characterize the cellular inflammatory infiltrate present around these hyperplasic areas.The hyperplasia was amplified by the AL treatment compared to controls. The data demonstrated that the gingival topical application of AL at saturation limit dose (10%), induced significant pro-inflammatory reactions not limited to the tissue treated, but extended to different tissues of the oral cavity (lips, tongue) and to lungs tissues where we noted an intense peribronchiolar hyperplasic lymphoid follicles with a high number of eosinophils. When given for a long period (3 weeks), the high inflammatory potential of AL was responsible of severe toxic effects with irreversible tissue lesions, particularly in lungs which limits the utilization of this plant as an anti-tumour product and must be forbidden to use in folk medicine.

Keywords: Aristolochia Longa, Rat-4NQO-Hyperplasia, Histopathological Analyses

1. Introduction

In recent years, there was a worldwide increase of folk medicine use based on plants. In Morocco, the use of traditional medicine is a widespread practice. The ethnobotanical and ethnopharmacological surveys conducted in different areas allowed the compilation of an inventory of 360 species and more than 500 prescriptions are recorded[1]. The use of plants in the form of infusions or decoctions is a common practice among people of rural communities and their use is increasing in urban populations. Despite the great number of plant extracts used in different human diseases[2] only a few of them have been scientifically explored.
Aristolochia longa L. (AL) (Aristolochiaceae) locally known as “Barraztam” is a species communally used in Moroccan traditional medicine[1; 3-4] for different treatments but mostly in cancer treatment[5-7].
The genus of Aristolochiaceae is a rich source of aristolochic acids (AAs) which are unique to this genus and of terpenoïds[8]. The AAs are associated with the development of aristolochic acid nephropathy (AAN) syndrome, characterized by chronic renal failure, tubule-interstitial fibrosis and urothelial cancer[9-11]. The use of AL during cancer treatment was reported in 16% of the renal failure observed in patients with malignancies[8; 10].
In a previous study we have determined that sub-chronic administration of the aqueous extract of AL at saturation limit dose of the plant produced severe and irreversible renal toxic effects in mice due to high immune-stimulation activity[12].
The in vivo anti-tumour effect of this plant has never been investigated before. We therefore developed an experimental gingival hyperplasia model in immune-competent rats to study the in vivo action of an aqueous extract of AL on the evolution of the hyperplasia. We also aimed to better understand its toxicological potential and to characterize the cellular inflammatory infiltrate present around these hyperplasic areas.

2. Material and Methods

2.1. Plant Material

Aristolochia longa L. Subsp. Aristolochia paucinervis Pomel[13; 14] was collected in May 2009 at 30 Km south of Marrakech City (Morocco).The plant was authentified and a voucher specimen was deposited (No 61318) in the Herbarium of National Scientific Institute of Rabat (Morocco).

2.2. Preparation of the Aqueous Extract of Aristolochia longa L. rhizomes

The vegetal material was washed with water, and then dried at room temperature for 48h to 92h. The aqueous extract was prepared by adding 500mL of distilled water to 50g of AL dry rhizomes powder. After 24h of maceration under magnetic stirring at room temperature, the mixture was centrifuged, filtered, and then concentrated in a rotary vacuum evaporator. The extracted material (yield of approximately 10% w/v) was dissolved in 0, 9% NaCl solution and stored at – 20°C in the dark until further use.

2.3. Animals and in Vivo Experiments

Wistar rats (n=12) aged 8 weeks old weighting approximately 250g, were obtained from the animal colony of our department. They were maintained under controlled conditions of temperature (24 ± 2°C), light-dark periods of 12 hours, and housed in groups of three or four per cage with free access to water and commercial diet.
4-Nitroquinoline-N-oxide (4-NQO) is a water soluble carcinogen, which induces tumours predominantly in the oral cavity. It produces all the stages of oral carcinogenesis[15; 16].The experiment was designed to examine the modifying effects of aqueous extract of (AL) during the initiation and post-initiation phases of 4NQO-induced oral tumorigenesis in Wistar rats[16; 17]. 4NQO (Sigma, USA) was obtained as a powder and was dissolved to a final concentration of 10 mg/ml. Fresh aliquots were obtained for every brush application. 4NQO was applied on gingival tissue with a No. 2 brush. The procedure was repeated 3 times a week for 16 weeks[18; 19]. The rats were restrained from drinking the first hour after 4NQO application. After the application period (16 weeks), a 10% AL solution was applied on gingival tissue of rats (n=6) with a No.2 brush daily for 3 weeks. A group of rats (n=6) not treated by AL solution was used as control.

2.4. Histopathological Examination

At the end of the experimental period, the rats were sacrificed by cerebral dislocation after inhalation anesthesia and different tissues (lip, tongue, gingival, lung) were removed and fixed in freshly 10% buffered formalin. All the tissues were trimmed, dehydrated, cleared, embedded in paraffin blocks, sectioned into 5 μm sections and stained by hematoxylin and eosin (H.E.) stain. Histopathological evaluation was performed with a light microscope by a pathologist.
All the experiments were performed in the morning according to current guidelines for the care of the laboratory animals and the ethical guidelines for the investigation of experimental pain in conscious animals[20], in accordance with the internationally accepted principles for laboratory animal use and care (EEC Directive of 1986; 86/609/EEC).

3. Results

To obtain and validate evidence for or against the use of AL as an antitumor product and in order to learn about its in situ mechanisms of immunological reactions, slowly developing gingival hyperplasia was initiated by application of a carcinogen to the anterior surface of the gingival of immune-competent Wistar rats. After 12 weeks application of 4NQO, a carcinogenic product, all the animals developed a white rough appearance of their gingival (Fig. 1a). No apparent abnormal clinical signs were noticed on the lip, tongue, liver and lungs in all periods evaluated. After 3-weeks treatment by a topical application of an aqueous extract of AL (10%), an increase in ulcer surrounded with severe inflammation was observed (Fig.1b).
Figure 1. Morphological change of gingival tissue of 4-NQO treated rats
The histopathological analysis has shown that no tumour developed after 4NQO application in any of the organs examined. Only inflammatory reactions were observed and were mild, sub acute and non specific in the lips (Figure 2b) and in gingival tissues (Figure 3b).
Figure 2. Histopathological changes in lip tissues. (a) Lip tissues of control rats, (Magnification x 5) (b) Lip tissues of rats treated with 4-NQO only: mild mononuclear inflammatory infiltrate; (x40). (c) Lip tissues of rats treated with 4-NQO and with AL: Intense polymorphous inflammatory infiltrate with eosinophils and exocytose; (x40).
The most significant changes were observed in the lungs with the development of peribronchiolar hyperplasic lymphoid follicles and polymorphous interstitial inflammation (Figure 4b). No significant changes were observed in the tongue (Figure 5b) and in the liver tissues (data not shown).
Figure 3. Histopathological changes in gingival tissues
The inflammatory reactions in the lips (Figure 2c), gingival (Figure 3c) and lung tissues were more pronounced after AL treatment with eosinophils polynuclears infiltrates in the lips and gingival tissues. In the lungs tissues, besides the polymorphous interstitial inflammatory infiltration, there were either an intense peribronchiolar hyperplasic lymphoid follicles or peribronchiolar and perivascular lymphoid nodules with fibrosis (Figure 4c).
A mild mononuclear inflammation was observed in the tongue (Figure 5c) and no significant changes were noted in the liver tissue.
Figure 4. Histopathological changes in Lung tissues

4. Discussion

The data presented in this study demonstrate that the gingival topical application of an aqueous extract of AL at saturation limit dose (10%), induced significant pro-inflammatory reactions not limited to the tissue treated, but extended to different tissues of the oral cavity (lips, tongue) and to lung tissues where we noted an intense peribronchiolar hyperplasic lymphoid follicles with polymorphous interstitial inflammatory infiltration and congestion.
Figure 5. Histopathological changes in tongue tissues
AA-I and AA-II, the major components of AL rhizome, were shown to possess immune-stimulatory properties[21]. In a previous study we demonstrated that in vivo the aqueous extract of AL induce an immune-stimulatory reaction in mice by amplifying the humoral and cellular immune reaction when given orally[12]. This pro-inflammatory reaction observed in these experimental conditions can be attributed to an immunostimulating action of AL.
Systemic immunologic status of patients bearing tumours is usually suppressed. This suppression can be measured as lowered activity of the peripheral lymphocytes[22] and a decrease in their number[23; 24] The suppression is mediated mainly through factors secreted by the tumour and the interaction between the growing and metastasizing tumour and the host environment[25; 26].
The myth of the anti-tumour[1; 5-7] plant can be explained by the fact that AL extract can induce an antitumor activity by its immune-stimulatory action, induction of inflammatory reaction and a high cytotoxicity followed by the development of tissue necrosis. The hyperplasia induced by the 4NQO was amplified by the AL treatment compared to controls. A high number of mononuclear cells infiltrates and lymphoid follicles and nodes were observed in AL treated animals. We also observed a high number of eosinophils in the different tissues examined. The mechanisms of the inflammatory reaction and cytotoxicity can be explained by the fact that after their activation by AAs, the eosinophils release the reactive oxygen species (ROS) as early mediators. Than the NADPH oxydase catalyzes the reduction of oxygen to superoxide. This is then transformed by superoxide dismutase to hydrogen peroxide (H2O2). Under the action of eosinophil peroxidase, H2O2 may be converted into singlet oxygen[26; 27]. All these reactive oxygen species give the eosinophils a pro-inflammatory potential and a cytotoxicity action which might have hindered tumour development normally induced by 4NQO; it might therefore be interesting to take more time to induce the development of a tumour and evaluate this presumed antitumor effect of the plant. However, although AL extract was topically applied on the gingival tissue it also induced inflammatory reactions in other tissues the most significant being in the lungs. Moreover, when given orally, aqueous extract of AL induced severe toxic effects with irreversible tissue lesions particularly in lungs, kidneys and liver[12]. Therefore, our results seem to indicate that the use of AL in folk medicine should be forbidden.

ACKNOWLEDGMENTS

This work was financially supported by the Minister of high education of the kingdom of Morocco and the CNRST of Morocco.

References

[1]  Bellakhdar J. La pharmacopée marocaine traditionnelle- Médecine arabe ancienne et savoirs populaires, Paris, Editions Ibis Press, 1997
[2]  Gonzalez-Tejero MR, Casares-Porcel M, Sanchez-Rojas CP, Ramiro- Gutierrez JM, Molero-Mesa J, Pieroni A, Giusti ME, Censorii, E, de Pasquale C, Della A, Paraskeva-hadijchambi D, Hadjichambis A, Houmani Z, EL-Demerdash M, El-Zayat M, Hmamouchi M, Eljohriq S. Medicinal plants in the Mediterranean Area: synthesis of the results of the project Rubia. Journal of Ethnopharmacoly, 2008 : 116, 341-357
[3]  Merzouki A, Ed-Derfoufi F, El-Allali A, Molero-Mesa J. Wild medicinal plants used by local Bouhmed population. Fitoterapia, 1997: 68, 444–460
[4]  Gadhi CA, Mory F, Benharref A, Lion C, Jana M, Weber M, Lozniewski A. Antibacterial activity of Aristolochia pauciner6is Pomel. Journal of Ethnopharmacology, 1999:67, 87–92
[5]  Mizuno M, Oka M, Iinuma M, Tanaka T. An aristolochic acid derivative of Aristolochia liukiuensis. Journal of Natural Product, 1990: 53, 179-187
[6]  De Pascual Teresa J, Urones JG, Fernandez A. An Aristolochic acid derivative from Aristolochia longa. Phytochemistry, 1983: 22, 2745-2747
[7]  Font Quer P. Diccionario de Botánica : Plantas Medicinales, Ed. Labor, Barcelona, 1973
[8]  Skalli S. « Bereztem »: Grande menace pour la santé d’un produit dit naturel. Journal de Toxicologie Maroc, 2010 : 5, 15. Maroc, 2010 : 5, 15
[9]  Wu TS, Damu AG, Su CR, Kuo PC. Terpenoids of Aristolochia and their biological Activities. Natural Product Report, 2004: 21, 594-624
[10]  Debelle FD, Vanherweghem JL, Nortier JL. Aristolochic acid nephropathy: a worldwide problem. Kidney Internationnal, 2008:74, (2), 158-69
[11]  Shaw D. Toxicological risks of Chinese herbs. , 2010:76, (17), 2012-8
[12]  Benzakour G, Benkirane N, Amrani M and Oudghiri M. Immunostimulatory potential of Aristolochia longa L. induced toxicity on liver, intestine and kidney in mice. Journal of Toxicology and Environnemental Health Sciences, 2011: 3(8) 214-222
[13]  Maire R. Flore de l’Afrique du Nord. Encyclopedie Biologique, LVIII, vol. VII. Lechevalier, Paris, 1961 :216– 230.
[14]  Fennane M, Mathez I, Ouyahya A, Raynaud C. Eléments pour la flore pratique du Maroc, Naturalia Monspeliensia, 1986 :50, 5–52
[15]  Aubry K, Paraf F, Monteil J, Bessède JP, Rigaud M. Characterization of a new rat model of head and neck squamous cell carcinoma. In vivo, 2008:22, (4), 403-408
[16]  Ribeiro DA, Fávero Salvadori DM. Gingival Changes in Wistar Rats after Oral Treatment with 4-Nitroquinoline 1-Oxide. European Journal of Dental, 2007:1, 152-157
[17]  Kanojia D, Vaidya MM. 4-nitroquinoline-1-oxide induced experimental oral carcinogenesis. Oral Oncology, 2006:42, 655-667
[18]  Hawkins BL, Heniford BW, Ackermann DM, et al. 4NQO carcinogenesis: a mouse model of oral cavity squamous cell carcinoma. Head Neck, 1994:16, 424-432
[19]  Gannot G, Buchner A., Keisari Y. Interaction between the immune system and tongue squamous cell carcinoma induced by 4-nitroquinoline N-oxide in mice. Oral Oncology, 2004: 40, 287-297
[20]  Zimmermann M. Ethical Guidelines for Investigations of Experimental Pain in Conscious Animals. Pain, 1983:16, 109-110
[21]  Pozdzik AA, Berton A, Schmeiser HH, Missoum W, Decaestecker C, Salmon IJ, Vanherweghem JL, Nortier JL. Aristolochic acid nephropathy revisited: a place for innate and adaptive immunity. Histopathology, 2010:56, (4), 449-63
[22]  Heimdal JH, Aarstad HJ, Klementsen B, Olofsson J. Peripheral blood mononuclear cell responsiveness in patients with head and neck cancer in relation to tumour stage and prognosis. Acta Otolaryngologica, 1999:119, 281—284
[23]  Eastham RJ, Mason JM, Jennings BR, Belew PW, Maguda TA. T-cell rosette test in squamous cell carcinoma of the head and neck. Archives of Otolaryngoly, 1976:102, 171—175
[24]  Bier j, Nickisch U, Platz H. The doubtful relevance of nonspecific immune reactivity in patients with squamous cell carcinoma of the head and neck region. Cancer, 1983:52, 1165—1172
[25]  Young MRI, Wright MA, Lozano Y, Matthews JP, Benefield J, Prechel MM. Mechanisms of immune suppression in patients with head and neck cancer: influence on the immune infiltrate of the cancer. Internationnal Journal of Cancer, 1996:67, 333—338
[26]  Taitz A, Petruzzelli G, Pak AS, Wright MA, Matthews JP, Raslan WF, et al. Immune parameters of mice bearing human head and neck cancer. Cancer Immunology Immunotherapy, 1995:40, 283—291
[27]  Thomas EL, Bozeman PM, Jefferson MM, King CC. "Oxidation of bromide by the human leukocyte enzymes myeloperoxidase and eosinophil peroxidase. Formation of bromamines. Journal of Biological Chemistry, 1995:270, (7), 2906-13